Sign In
Last checked at 
19 Nov 2009 15:07
ο»Ώ
Annex DTR3
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
All relevant boxes should be completed in block capital letters.
|
1. |
Name of the issuer HIKMA PHARMACEUTICALS PLC |
2. |
State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R,Β (ii) a disclosure made in accordanceΒ LR 9.8.6R(1) or (iii) a disclosure made in accordance with section 793Β of the Companies Act (2006). (i) |
|
3. |
Name of person discharging managerial responsibilities/director MAJDA MISHLAWI |
4. |
State whether notification relates to a person connected with a person discharging managerialΒ responsibilities/director named in 3 and identify theΒ connected person N/A |
|
5. |
Indicate whether the notification is in respect of aΒ holding of the person referred to in 3 or 4 above orΒ in respect of a nonbeneficial interest 1 3Β ABOVE |
6. |
Description of shares (including class), debentures orΒ derivatives or financial instruments relating to shares ORDINARY SHARES OF 10P EACH |
|
7. |
Name of registered shareholders(s) and, if moreΒ than one, the number of shares held by each ofΒ them MAJDA MISHLAWI |
8. |
State the nature of the transaction EXERCISEΒ ANDΒ SALEΒ OF 120,000Β ORDINARY SHARESΒ AT $0.9075 PER SHAREΒ UNDER THE TERMS OF THE 2004 STOCK OPTION PLAN |
|
9. |
Number of shares, debentures or financial instruments relating to shares acquired N/A |
10. |
Percentage of issued class acquired (treasury shares ofΒ that class should not be taken into account whenΒ calculating percentage) N/A |
|
11. |
Number of shares, debentures or financial instruments relating to shares disposed 120,000 |
12. |
Percentage of issued class disposed (treasury shares ofΒ that class should not be taken into account whenΒ calculating percentage) 0.063% |
|
13. |
Price per share or value of transaction 5.0147Β PENCEΒ PER SHARE |
14. |
Date and place of transaction LONDON |
|
15. |
Total holding following notification and totalΒ percentage holding following notification (anyΒ treasury shares should not be taken into accountΒ when calculating percentage) 161,391 (0.084%) |
16. |
Date issuer informed of transaction 18 NovemberΒ Β 2009 |
If a person discharging managerial responsibilities has been granted options by the issuer
complete the following boxes
|
17. |
Date of grant N/A |
18. |
Period during which or date on which exercisable N/A |
|
19. |
Total amount paid (if any) for grant of the option N/A |
20. |
Description of shares or debentures involved (classΒ and number) N/A |
|
21. |
Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time ofΒ exercise N/A |
22. |
Total number of shares or debentures over whichΒ options held following notification N/A |
|
23. |
Any additional information N/A |
24. |
Name of contact and telephone number for queries VictoriaΒ Hames 0207 399 2766 |
|
Name of authorised official of issuer responsible for making notification Henry Knowles Date of notification 18 NovemberΒ Β 2009 |
Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.
|
(1) |
An issuer making a notification in respect of a transaction relating to the shares orΒ debentures of the issuer should completeΒ boxes 1 to 16, 23 and 24. |
|
(2) |
An issuer making a notification in respect of a derivative relating the shares of theΒ issuer should completeΒ boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. |
|
(3) |
An issuer making a notification in respect of options granted to a director/personΒ discharging managerial responsibilities should completeΒ boxes 1 to 3Β and 17 to 24. |
|
(4) |
An issuer making a notification in respect of a financial instrument relating to theΒ shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11,Β 13, 14, 16, 23 and 24. |
Follow the stocks
